Health Catalyst Inc (HCAT)

Featured in High-Beta Stocks

Health Catalyst, Inc. is a healthcare technology company listed on NASDAQ under the ticker HCAT. As a common stock issuer, it develops data and analytics tools and related services for healthcare organizations in the United States. The company operates through two segments: Technology and Professional Services. Its platform is designed to bring together data from multiple clinical and administrative systems, while its software applications support areas such as clinical improvement, revenue and cost analysis, ambulatory operations, and registry reporting. Health Catalyst also provides consulting and implementation support, including data governance, modeling, quality improvement, cost accounting, data abstraction, and population health-related work. The company serves a range of healthcare and adjacent organizations, including hospitals, physician groups, accountable care organizations, health insurers, and healthcare technology vendors. Founded in 2008 and headquartered in South Jordan, Utah, it was previously known as HQC Holdings, Inc. before adopting its current name in 2017.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-HCAT
$2.63
23.5% Upside
Undervalued
$2.10
-1.4% Downside
Fair
Good
0.0%
August 12, 2026
-0.6x
1.1x
0.5x
159.6 M
219.1 M
51.7%
79.5%
-7.5
-6.9%
Valuation • Fair Value

Health Catalyst Inc (NASDAQ-HCAT) Fair Value by Valuation Model

Compare the primary fair value estimate for Health Catalyst Inc (NASDAQ-HCAT) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$2.63

Estimated upside of 23.5% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$3.05

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$2.59

Earnings power value estimate.

Comps Fair Value

$2.57

Comparable-company valuation reference.

Analyst Price Target

$2.10

Analysts imply downside of 1.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Health Catalyst Inc (NASDAQ-HCAT) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Health Catalyst Inc (NASDAQ-HCAT)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

302.5 M

Current operating scale indicator.

Revenue Forecast

263.6 M

Forward revenue estimate.

EBITDA

863 K

Current operating profitability reference.

EBITDA Forecast

32.069 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Health Catalyst Inc (NASDAQ-HCAT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Health Catalyst Inc (NASDAQ-HCAT)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-5.78

No elevated caution signal from this screen.

Altman Z-Score

-7.5

Lower score that deserves closer risk review.

FCF / Net Income

-6.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Health Catalyst Inc (NASDAQ-HCAT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Health Catalyst Inc (NASDAQ-HCAT)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 12, 2026

Days to Earnings

22

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Health Catalyst Inc (NASDAQ-HCAT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Health Catalyst Inc (NASDAQ-HCAT) Stock Forecast & Technical Outlook

Review Health Catalyst Inc (NASDAQ-HCAT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Health Catalyst Inc (NASDAQ-HCAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Health Catalyst Inc (NASDAQ-HCAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Health Catalyst Inc (NASDAQ-HCAT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Health Catalyst Inc (NASDAQ-HCAT) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Health Catalyst Inc (NASDAQ-HCAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Health Catalyst Inc (NASDAQ-HCAT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Health Catalyst Inc (NASDAQ-HCAT) has a Hold consensus, with 2 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 5
Sell 0
FAQ Fast Investor Answers

Health Catalyst Inc (NASDAQ-HCAT) Stock FAQ

Quick answers about Health Catalyst Inc (NASDAQ-HCAT) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$2.63
Estimated upside 23.5%
Valuation Rating
Undervalued
Estimated upside of 23.5%
Analyst Target
$2.10
Implied downside 1.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Health Catalyst Inc (NASDAQ-HCAT) is $2.63. This implies an estimated upside of 23.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 23.5% versus the current market price.

The available analyst price target for Health Catalyst Inc (NASDAQ-HCAT) is $2.10. The analyst target implies estimated downside of 1.4%.

The current financial health read for Health Catalyst Inc (NASDAQ-HCAT) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Health Catalyst Inc (NASDAQ-HCAT) is August 12, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Health Catalyst Inc (NASDAQ-HCAT) is -0.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Health Catalyst Inc is 159.6 M.

The current enterprise value listed for Health Catalyst Inc is 219.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Health Catalyst Inc is NASDAQ-HCAT, and the stock is listed on NASDAQ.

Health Catalyst Inc (NASDAQ-HCAT) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Health Catalyst Inc is 51.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Health Catalyst Inc is 79.5%. Free float helps investors understand how much of the share base is available for public trading.